EZH2 and acute lymphoblastic leukemia: In fact, T-ALL was characterized by multiple epigenetic alterations, including DNA methyltransferases (DNMTs), enhancer of zeste homolog 2 (EZH2), histone deacetylases (HDACs), PHF6, etc., which were extensively reviewed [87,88,89,90].